|
|
DSpace at RU >
Browsing by Author Klijn, J.G.M.
Showing results 3 to 22 of 23
| Full Text | Issue Date | Title | Author(s) | | 2010 | BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. | Rijnsburger, A.J.; Obdeijn, I.M.; Kaas, R., et al |
| 2005 | Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. | Asperen, C.J. van; Brohet, R.M.; Meijers-Heijboer, E.J., et al |
| 2007 | The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study. | Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J., et al |
| 2007 | Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. | Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J., et al |
| 2007 | The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy. | Bresser, P.J.; Seynaeve, C.; Gool, A.R. van, et al |
| 2006 | Decreased risk of stroke among 10-year survivors of breast cancer. | Hooning, M.J.; Dorresteijn, L.D.A.; Aleman, B., et al |
| 2006 | Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. | Kriege, M.; Brekelmans, C.T.; Boetes, C., et al |
| 2004 | Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. | Kriege, M.; Brekelmans, C.T.; Boetes, C., et al |
| 2006 | Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. | Kriege, M.; Brekelmans, C.T.; Obdeijn, I.M., et al |
| 2007 | Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. | Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J., et al |
| 2005 | Hereditary breast cancer growth rates and its impact on screening policy. | Tilanus-Linthorst, M.M.; Kriege, M.; Boetes, C., et al |
| 1997 | A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families | Peelen, T.; Vliet, M. van; Petrij-Bosch, A., et al |
| 2004 | Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. | Seynaeve, C.; Verhoog, L.C.; Bosch, L.M. van de, et al |
| 2006 | Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. | Foekens, J.A.; Atkins, D.; Zhang, Y., et al |
| 2007 | Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing. | Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J., et al |
| 1996 | Prognostic significance of TP53 accumulation in human primary breast cancer : comparison between a rapid quantitative immunoassay and SSCP analysis | Witte, J.H. de; Foekens, J.A.; Lennerstrand, J.A., et al |
| 2004 | The prognostic value of BCAR1 in patients with primary breast cancer. | Dorssers, L.C.; Grebenchtchikov, N.J.; Brinkman, A.B., et al |
| 1997 | Prognostic value of TP53 protein accumulation in human primary breast cancer: an analysis by luminometric immunoassay on 1491 tumor cytosols | Berns, E.M.J.J.; Witte, J.H. de; Klijn, J.G.M., et al |
| 2007 | A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships. | Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J., et al |
| 2007 | Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer | Kriege, M.; Brekelmans, C.T.; Peterse, H., et al |
Showing results 3 to 22 of 23
|